- The Washington Times - Sunday, December 31, 2006


There’s a big change coming for pregnant women: Down syndrome testing no longer hinges on whether they’re older or younger than 35.

This week, the American College of Obstetricians and Gynecologists (ACOG) will begin recommending that every pregnant woman, regardless of age, be offered a choice of tests for this common birth defect.

The main reason: Tests far less invasive than the long-used amniocentesis are now widely available, some that can tell in the first trimester the risk of an unborn baby having Down syndrome or other chromosomal defects.

The new guideline is published in the January issue of the journal Obstetrics & Gynecology.

About 1 in 800 babies has Down syndrome, a condition where having an extra chromosome causes mental retardation, a characteristic broad, flat face and small head and, often, serious heart defects.

Age 35 was always a somewhat arbitrary threshold for urging mothers-to-be to seek testing, though the older women are, the higher their risk of having a baby with Down syndrome.

But it’s a gradual increase in risk — from 1 in 1,200 at age 25 to about 1 in 300 at age 35.

“It’s clear there’s no magic jump at 35,” said Dr. James Goldberg of San Francisco Perinatal Associates, a member of the ACOG committee that developed the guideline. “We’ve done away with age 35 because the screening tests have gotten much better.”

It’s not just a question of whether to continue the pregnancy. Prenatal diagnosis also is important for those who wouldn’t consider abortion, because babies with Down syndrome can need specialized care at delivery that affects hospital selection, he added.

The original age-35 trigger was chosen years ago when doctors had less information about the risk of Down syndrome, and the only choice for prenatal detection was an amnio, using a needle to draw fluid from the amniotic sac, Dr. Goldberg said. Amnios are highly accurate but were reserved for women at higher risk of an affected pregnancy because they occasionally cause miscarriage. A study this fall put the miscarriage risk at 1 in 1,600 pregnancies, far lower than previous estimates.

Also today, women have more options. Doctors already frequently offer younger women blood tests that don’t definitively diagnose Down syndrome like an amnio or a similar invasive test called chorionic villus sampling — but that can signal who’s at higher risk.

The newest method, topping ACOG’s recommendation for everyone, is a first-trimester screening that combines blood tests with a simple ultrasound exam, called a “nuchal translucency test” to measure the thickness of the back of the fetal neck.

Studies from England, where the nuchal translucency combo has been used for about a decade, and the United States conclude that the screening method is more than 80 percent accurate, with a very small risk of falsely indicating Down syndrome in a healthy unborn child. It is performed between 11 and 13 weeks into pregnancy, and women are usually given numerical odds of carrying an affected baby.

A woman determined to be high risk then still has time for an invasive test to tell for sure.

Copyright © 2018 The Washington Times, LLC. Click here for reprint permission.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide